Compass Point analyst Giuliano Bologna upgrades Iris Energy (NASDAQ:IREN) from Neutral to Buy and raises the price target from $6 to $6.5.
What’s Going On European Pharma Giant AstraZeneca Stock On Wednesday?
Japan approves AstraZeneca & Sanofi's Beyfortus for respiratory syncytial virus in neonates, infants, & children. Also, Truqap receives approval for unresectable or recurrent breast cancer. AstraZeneca challenges Arkansas law extending drug discounts to for-profit pharmacy chains, citing federal regulations."
